2025 was a year marked by seismic shifts in the health policy landscape. With 2025 in the rearview mirror, 2026 will be the year when many of these major changes are implemented – with more changes on the horizon.
This two-part webinar series will explore anticipated actions and provide insight on additional areas for potential policymaking in 2026. While many of these policy changes are crosscutting, our discussion will be divided into two parts: The first will focus on Medicaid, the Marketplaces, Medicare, and public health; the second will focus on prescription drugs and the life sciences industry.
Part 1: An Outlook on Federal Coverage Programs and Public Health
Thursday, January 29 2026
3:00 p.m.—4:00 p.m. ET
Learn the Manatt team’s 2026 outlook for Medicaid, Marketplaces, Medicare, and public health:
- What H.R. 1 policies, including fundamental changes to federal health coverage programs, are set to be implemented this year?
- How will newly remade public health advisory entities continue to affect public health?
- What Administration priorities in digital health and AI are most likely to take hold?
- What factors are most likely to drive the coverage landscape across federal programs?
Part 2: An Outlook for the Biopharmaceutical Industry: CMS and FDA?
Wednesday, February 11 2026
2:00 p.m.—3:00 p.m. ET
Learn the Manatt life sciences team’s public policy outlook for 2026:
- What elements of international reference pricing will take hold?
- How will Medicaid funding cuts put pressure on patient access to treatment?
- Which FDA medical product review areas will be impacted by operational and policy shifts?
- What factors will drive adoption of coverage for anti-obesity medicine in Medicare and Medicaid?
Please click here to register for the two-part webinar series.